# AptaPharma Inc. – FDA Inspection, Aug 14, 2026

Source: https://www.keypedia.com/records/fda_inspections/aptapharma-inc/5a27f40e-6ca9-448c-a9e6-9ab663ccfcec
Source feed: FDA_Inspections

> FDA inspection 1331256 of AptaPharma Inc., August 14, 2026. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1331256
- Company Name: AptaPharma Inc.
- Inspection Date: 2026-08-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1231140 - 2024-10-24
- [FDA Inspection 1205203 - 2023-05-15](https://www.keypedia.com/records/fda_inspections/aptapharma-inc/acbc1cae-f7f4-45ce-a9dd-baac18f57175)
- [FDA Inspection 1102699 - 2019-09-25](https://www.keypedia.com/records/fda_inspections/aptapharma-inc/412628c1-3ed7-4ab7-afc9-0f5453b9d583)
- [FDA Inspection 1045668 - 2018-03-16](https://www.keypedia.com/records/fda_inspections/aptapharma-inc/56b08717-7de1-4c2d-9b87-592490ed7578)
- FDA Inspection 884304 - 2014-06-23

## Related Officers

- [Company Rep](https://www.keypedia.com/people/michael-o-idowu/795647ab-8f6b-47cc-ae88-3b2c61192861)

Company: https://www.keypedia.com/companies/aptapharma-inc/8390ea00-697d-4f5d-9e50-407830a6b2ee

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248